281.20SEK+0.93%Mkt Cap: 9.09B SEKP/E: 123.86Last update: 2026-05-13
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)123.86
P/E (Forward)48.83
PEG—
P/B4.30
P/S10.89
EV/EBITDA64.80
EV/Revenue10.67
EPS (TTM)2.34
EPS (Forward)5.91
Cash Flow & Leverage
FCF Yield-1.00%
FCF Margin-10.88%
Operating CF101.07M SEK
CapEx (TTM)252.91M SEK
Net Debt/EBITDA-1.35
Net Debt-185.46M SEK
Technical
SMA 50246.45 (+14.1%)
SMA 200198.80 (+41.4%)
Beta1.42
S&P 52W Chg24.23%
Avg Vol (30d)107.15K
Avg Vol (10d)64.22K
Technical Indicators
RSI (14)56.2
MACD10.0031
MACD Signal12.9532
MACD Hist.-2.9500
BB Upper308.53 SEK
BB Middle285.80 SEK
BB Lower263.07 SEK
BB Width15.90%
ATR (14)12.35 SEK
Vol Ratio (20d)0.19x
52W Range
160.0068% of range338.00
52W High338.00 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
EBITDA Margin16.47%
Profit Margin3.10%
Oper. Margin13.26%
ROE1.19%
ROA1.06%
Revenue Growth10.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.06
Current Ratio4.52
Quick Ratio3.10
Book Value/Sh67.09 SEK
Cash/Share9.782 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.31.50M
Float25.13M
Insiders7.85%
Institutions59.98%
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)337.00 SEK
Target Range300.00 SEK – 385.00 SEK
# Analysts5
Company
Market Cap9.09B SEK
Enterprise Value8.91B SEK
Revenue (TTM)834.53M SEK
Gross Profit599.49M SEK
Net Income (TTM)25.16M SEK
Revenue/Share26.49 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees199
Last Price281.20 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718